Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Rectal Neoplasms 1Pancreatic cancer, adult 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Pancreatic Ductal 1

Interventions

Gemcitabine 5130-nm albumin-bound paclitaxel 3nimotuzumab 2Oxaliplatin 2Leucovorin 2Irinotecan 2Hematologic Tests 2Fluorouracil 2Albumin-Bound Paclitaxel 2surufatinib 1napabucasin 1irinotecan sucrosofate 1ensituximab 1Taxes 1S 1 (combination) 1Radiofrequency Ablation 1Paclitaxel 1Mass Screening 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic cancer, adult × ensituximab × Clear all
NCT01834235 2025-05-07

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Precision Biologics, Inc

Phase 1/2 Terminated
81 enrolled 13 charts
Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡